Yerramilli-rao Bobby Satyadev

Type: individual

Citizenship: British

Age: 59

Manages

Investor
Advanced report
* may contain former positions

Last changes

  1. Genome Therapeutics Ltd
    Cessation of Samuel Aparicio as a person with significant control on 2025-08-08
  2. Genome Therapeutics Ltd
    Statement of capital following an allotment of shares on 2025-08-08
  3. Genome Therapeutics Ltd
    Cessation of Shankar Balasubramanian as a person with significant control on 2025-08-08
  4. Genome Therapeutics Ltd
    Change of share class name or designation
  5. Genome Therapeutics Ltd
    Resolutions
See all events

Co-directors of Yerramilli-rao Bobby Satyadev

Klein Saul Charles
Mahmood Saiyed Ibraheem
Aparicio Samuel
Mchugh Dan
Balasubramanian Shankar Prof Sir
Mbm Secretarial Services Ltd

FAQ about Yerramilli-rao Bobby Satyadev

Looking for leads in the UK?

Try our FREE App—access UK datasets with limited features!

Try for FREE Learn more

GDPR compliance

The data on this page is derived from the public records of Companies House and is processed by fully automated ML and AI algorithms. Please note that this data may contain errors. It is provided on an "as is" basis without any guarantees regarding completeness, accuracy, usefulness, or timeliness.

As per the guidance on personal data on the Companies House register, this personal data is exempt from certain data protection requirements. This is because the law mandates the public availability of this information. Other organisations, including ours, have the legal right to replicate information from the public register. For inquiries or concerns regarding data protection and privacy, please contact us at gdpr@corpsignals.com.